Komori
Other Disclosures3769GMO Payment Gateway,Inc.Information and Communications, Services and Others

GMOリザーブプラス launches an option for secondary and tertiary-care veterinary hospitals on Animary byGMO to digitize referral reservations and information sharing between veterinary hospitals

GMOリザーブプラス has added and begun offering an option to “Animary byGMO,” a reservation management system for veterinary hospitals, that enables primary-care veterinary hospitals and 1.5- and secondary-care veterinary hospitals to share referral appointments, patient information and treatment progress between hospitals.

Worth reading
75Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Animary byGMOInter-veterinary-hospital referral appointment function
Applicable field (uses covered by this announcement)

Referral appointments, information sharing and veterinary medicine between primary-care veterinary hospitals and 1.5- and secondary-care veterinary hospitals

Launch date1 October 2026 (actual results and service launch)
What the company reported numerically
Usage history

ネオベッツ VR センター is the first adopter; use began on 1 October 2026.

Relationship between the counterparty and the company
GMO Payment Gateway,Inc.3769
Relationship with the Company

ネオベッツ VR センター supervised the development of this option and is its first adopter. It began using the option on 1 October 2026.

Counterpartyネオベッツ VR センター

An advanced secondary-care veterinary facility that opened in Osaka in 2005. It has departments of oncology and general medicine, orthopedics, ophthalmology and neurosurgery. It performs approximately 2,000 surgical procedures and approximately 4,000 CT and MRI imaging examinations annually.

Registration number and expiry date

Patent No. 7897454 (patented technology used in the medical collaboration function of “メディカル革命 byGMO”)

Location (as indicated in this announcement)

Osaka (ネオベッツ VR センター)

Approximately 2,000 surgical procedures and approximately 4,000 CT and MRI imaging examinations annually
Offering price

The referring veterinary hospital can use the service free of charge. The price for the adopting 1.5- and secondary-care veterinary hospital is Not disclosed.

The company does not address Contract Value / Impact on Business Performance.

Source (materials cited by the company)

According to 株式会社ネオ・ベッツ (“the first in Japan among private-sector facilities,” according to its explanation)

Announced details
ItemDetails
Names of Products / Services CoveredAnimary byGMO, Inter-veterinary-hospital referral appointment function
Counterpartyネオベッツ VR センター
Counterparty overviewAn advanced secondary-care veterinary facility that opened in Osaka in 2005. It has departments of oncology and general medicine, orthopedics, ophthalmology and neurosurgery. It performs approximately 2,000 surgical procedures and approximately 4,000 CT and MRI imaging examinations annually.
Relationship with the Companyネオベッツ VR センター supervised the development of this option and is its first adopter. It began using the option on 1 October 2026.
Offering priceThe referring veterinary hospital can use the service free of charge. The price for the adopting 1.5- and secondary-care veterinary hospital is Not disclosed.
Launch date1 October 2026 (actual results and service launch)
Applicable areaReferral appointments, information sharing and veterinary medicine between primary-care veterinary hospitals and 1.5- and secondary-care veterinary hospitals
Registration number and expiry datePatent No. 7897454 (patented technology used in the medical collaboration function of “メディカル革命 byGMO”)
LocationOsaka (ネオベッツ VR センター)
Location scaleApproximately 2,000 surgical procedures and approximately 4,000 CT and MRI imaging examinations annually
Usage historyネオベッツ VR センター is the first adopter; use began on 1 October 2026.
SourceAccording to 株式会社ネオ・ベッツ (“the first in Japan among private-sector facilities,” according to its explanation)
Items this document does not state (6)
Contract ValueContract DateAward/certification nameAwarding / certifying bodyQuantitative EffectsImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To consolidate referral appointments previously handled through separate channels such as telephone, fax and email on the web, reducing the administrative burden of checking and re-entering appointment information, reconfirming missing information and correcting communication errors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
GMOリザーブプラス launches an option for secondary and tertiary-care veterinary hospitals on Animary byGMO to digitize referral reservations and information sharing between veterinary hospitals | GMO Payment Gateway,Inc. (3769) timely disclosure | Komori